By Connor Hart

Shares of Accendra Health climbed after the company narrowed its first-quarter loss and reported better-than-expected adjusted earnings.

The stock rose 15% to $4.12 on Monday, extending its nearly 50% run so far this year.

The home-based care company before the bell narrowed its loss to $6.47 million, or 8 cents a share, from $25 million, or 32 cents a share, in the same quarter last year.

Stripping out certain one-time items, the loss came out to 4 cents a share. Analysts polled by FactSet expected an adjusted loss of 10 cents a share.

Net revenue fell 6.8% to $627.8 million, below Wall Street models for $644.2 million.

Chief Executive Edward Pesicka said the results were in line with expectations, as Accendra continues its transformation into a pure-play home-based care company. The transformation includes its divestiture of Owens & Minor, which is on track and going according to schedule, he added.

"Also, this morning we announced the receipt of commitments from existing creditors that will allow us to conduct a holistic reset of our capital structure and establish the long-term foundation for Accendra Health," Pesicka added. "Key benefits include paying off our 2027 maturities, a multi-year extension of our revolving credit facility, meaningful debt reduction, and other maturity extensions."

Looking forward, the company backed its full-year outlooks for net revenue and adjusted Ebitda, or earnings before interest, taxes, depreciation and amortization.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

May 11, 2026 10:33 ET (14:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.